Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis—Burkina Faso, 2014–2015

OBJECTIVES: We evaluate early impact of 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal meningitis in Burkina Faso. METHODS: Nationwide surveillance gathered demographic/clinical information and cerebrospinal fluid (CSF) results for meningitis cases. Pneumococcal cases were confirme...

Descripción completa

Detalles Bibliográficos
Autores principales: Kambiré, Dinanibè, Soeters, Heidi M., Ouédraogo-Traoré, Rasmata, Medah, Isaïe, Sangaré, Lassana, Yaméogo, Issaka, Sawadogo, Guetawendé, Ouédraogo, Abdoul-Salam, Ouangraoua, Soumeya, McGee, Lesley, Srinivasan, Velusamy, Aké, Flavien, Congo-Ouédraogo, Malika, Ky Ba, Absatou, Whitney, Cynthia G., Novak, Ryan T., Van Beneden, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821694/
https://www.ncbi.nlm.nih.gov/pubmed/29253559
http://dx.doi.org/10.1016/j.jinf.2017.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821694/
https://www.ncbi.nlm.nih.gov/pubmed/29253559
http://dx.doi.org/10.1016/j.jinf.2017.12.002

Ejemplares similares